We are live on ! Find out more
ZURA icon

Zura Bio

34 hedge funds and large institutions have $58.1M invested in Zura Bio in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

300% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 3

36% more funds holding

Funds holding: 2534 (+9)

20% more capital invested

Capital invested by funds: $48.5M → $58.1M (+$9.59M)

Holders
34
Holders Change
+9
Holders Change %
+36%
% of All Funds
0.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
6
Reduced
1
Closed
3
Calls
$183K
Puts
Net Calls
+$183K
Net Calls Change
-$31K

ZURA Hedge Fund Activity: Q1 2022 in Review

34 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q1 2022, worth a combined $58.1M — up 20% from $48.5M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ZURA positions and 3 closed out — a net gain of 9 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $4.43M. The largest seller was Boussard & Gavaudan Investment Management, exiting entirely with an estimated $3.69M sold.

  • 34 institutional investors held Zura Bio (ZURA) as of Q1 2022, up from 25 in Q4 2021.
  • Funds reported $58.1M of Zura Bio stock for Q1 2022, up 20% quarter-over-quarter.
  • 12 funds opened new Zura Bio positions in Q1 2022 and 3 closed out, a net change of +9 holders.
  • The largest Zura Bio buyer in Q1 2022 was Shaolin Capital Management, an estimated $4.43M added.
  • The largest Zura Bio seller in Q1 2022 was Boussard & Gavaudan Investment Management, an estimated $3.69M sold.

Based on aggregated 13F filings for Q1 2022.